Activation of coagulation and platelets by candidate membranes of implantable devices in a whole blood model without soluble anticoagulant

Journal of Biomedical Materials Research - Part A - Tập 101A Số 2 - Trang 575-581 - 2013
Andrey Sokolov1, Bernt Christian Hellerud1, Tor Inge Tønnessen2, Erik Johannessen3, Tom Eirik Mollnes1,4
1Department of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, P.O. 4950, Nydalen 0424 Oslo, Norway.
2Department of Emergencies and Critical Care Medicine, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. 4950, Nydalen 0424 Oslo, Norway
3Department of Micro‐ and Nanosystems Technology, Vestfold University College, P.O. Box 2243, N‐3103, Tønsberg, Norway
4Research Laboratory, Somatic Research Centre, Nordland Hospital, Bodø, and University of Tromsø, Norway

Tóm tắt

AbstractImplantable devices are challenged with thrombus formation at their biomaterial interface. Thus the importance of identifying compatible biomaterials that will help to improve the performance of these devices are becoming increasingly paramount. The aim of this study was to evaluate the activation of coagulation and platelets by candidate membranes considered for use in implantable devices on the basis of an adapted whole blood model without soluble anticoagulants. Evaluated materials were incubated with whole blood without soluble anticoagulant in wells coated with heparin. Prothrombin fragment 1+2 (PTF 1+2), thrombin‐antithrombin complex (TAT), and β‐thromboglobulin (BTG) were analyzed in plasma samples using enzyme immunoassays. The C5 inhibitor eculizumab was used to evaluate the role of complement. Incubation of two of the polyamide membranes PAR and PATF led to an increase in concentration of PTF 1+2 and TAT (p < 0.01 for PAR, ns for PATF). The BTG concentration was significantly increased for five materials [PAR, PATF, polycarbonate (PC), and two polyarylethersulphone membranes PAES‐1 and PAES‐2]. Complement inhibition had no effect on coagulation or platelet activation induced by PAR and PATF. In conclusion, PAR and PATF were not compatible with blood and should be avoided for use in implantable devices. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.

Từ khóa


Tài liệu tham khảo

Clagett GP, 1994, Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 1486

10.1016/j.biomaterials.2008.12.041

10.1007/s10439-011-0256-y

10.1111/j.1525-1594.1990.tb01606.x

10.1002/jbm.a.34054

Ratner BD, 2004, Biomaterials Science: An Introduction to Materials in Medicine

10.1213/ane.0b013e31819bceb1

10.1016/j.biomaterials.2004.01.023

10.1182/blood.V88.9.3432.bloodjournal8893432

10.1067/mlc.2001.116486

10.4049/jimmunol.168.11.5786

10.1002/jemt.20854

10.1016/j.biomaterials.2009.05.044

10.1016/S0142-9612(98)00210-5

10.1016/0142-9612(84)90075-9

10.1016/j.thromres.2004.06.028

10.1016/j.addr.2011.06.012

10.1016/j.it.2007.02.006

10.1073/pnas.0903613106

10.1016/j.athoracsur.2004.02.005

10.1016/1054-8807(93)90059-B

Mollnes TE, 2002, Essential role of the C5a receptor in E. coli‐induced oxidative burst and phagocytosis revealed by a novel lepirudin‐based human whole blood model of inflammation, Blood, 100, 1869

10.1002/jbm.a.32034

10.1177/193229681100500625

10.1002/jbm.b.31855

10.3109/10731198309118804

10.1016/S0022-5223(95)70023-4

10.1111/j.1365-3083.1985.tb01871.x

10.1111/j.1365-2249.1993.tb05898.x

Mollnes TE, 2003, Measurement of complement activation, Methods Mol Biol, 225, 69

10.1038/nbt1344

10.1016/j.molimm.2011.04.014

2002, Biological Evaluation of Medical Devices‐Part 4: Selection of Tests for Interactions with Blood

10.1055/s-0037-1614342

10.1378/chest.124.3_suppl.18S

10.1016/j.biomaterials.2006.10.020

10.1681/ASN.V12150

10.1038/ki.1984.155

10.1016/0142-9612(88)90069-5

10.1177/039139889201500610

10.1046/j.1523-1755.2001.00009.x

10.1016/0142-9612(94)90038-8

10.1007/s10856-007-3006-9

10.1159/000329051

Davies MI, 1995, Microdialysis sampling for hepatic metabolism studies. Impact of microdialysis probe design and implantation technique on liver tissue, Drug Metab Dispos, 23, 1072

10.1007/BF00228411

10.1002/jbm.a.31818

10.1016/S0003-4975(03)01519-4

10.1016/j.biomaterials.2003.12.014

10.1016/j.biomaterials.2010.02.036